Create Medic Co., Ltd. (5187.T)
JPY 942.0
(0.43%)
JPY 942.0
(0.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.39 Billion JPY | -1.89% |
| 2022 | 1.47 Billion JPY | -4.44% |
| 2021 | 1.43 Billion JPY | 8.14% |
| 2020 | 1.39 Billion JPY | -6.31% |
| 2019 | 1.49 Billion JPY | 8.56% |
| 2018 | 1.33 Billion JPY | 8.76% |
| 2017 | 1.12 Billion JPY | 6.39% |
| 2016 | 1.15 Billion JPY | 18.18% |
| 2015 | 951.23 Million JPY | -27.7% |
| 2014 | 1.18 Billion JPY | 7.09% |
| 2013 | 1.21 Billion JPY | 5.25% |
| 2012 | 1.2 Billion JPY | -1.75% |
| 2011 | 1.3 Billion JPY | -8.95% |
| 2010 | 1.35 Billion JPY | -11.0% |
| 2009 | 1.38 Billion JPY | -6.22% |
| 2008 | 1.62 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 266.59 Million JPY | -30.19% |
| 2024 Q2 | 366.45 Million JPY | 190.08% |
| 2024 Q3 | 317.59 Million JPY | -60.61% |
| 2023 Q2 | 257.25 Million JPY | 107.87% |
| 2023 Q1 | 123.75 Million JPY | 898.68% |
| 2023 Q3 | 283.99 Million JPY | 10.4% |
| 2023 Q4 | 351.46 Million JPY | 23.76% |
| 2023 FY | - JPY | -1.89% |
| 2022 Q1 | 225.71 Million JPY | 26.72% |
| 2022 Q4 | -15.49 Million JPY | -105.07% |
| 2022 Q3 | 305.57 Million JPY | 1.12% |
| 2022 FY | - JPY | -4.44% |
| 2022 Q2 | 302.18 Million JPY | 33.88% |
| 2021 Q1 | 167.07 Million JPY | -56.26% |
| 2021 FY | - JPY | 8.14% |
| 2021 Q2 | 379.92 Million JPY | 127.4% |
| 2021 Q3 | 296.54 Million JPY | -21.95% |
| 2021 Q4 | 178.11 Million JPY | -39.94% |
| 2020 Q4 | 381.96 Million JPY | 89.41% |
| 2020 FY | - JPY | -6.31% |
| 2020 Q1 | 28.38 Million JPY | -92.78% |
| 2020 Q2 | 366.01 Million JPY | 1189.43% |
| 2020 Q3 | 201.65 Million JPY | -44.9% |
| 2019 FY | - JPY | 8.56% |
| 2019 Q4 | 393.03 Million JPY | 71.15% |
| 2019 Q2 | 383.1 Million JPY | 454.74% |
| 2019 Q1 | 69.06 Million JPY | -79.37% |
| 2019 Q3 | 229.64 Million JPY | -40.06% |
| 2018 Q4 | 334.74 Million JPY | 87.72% |
| 2018 FY | - JPY | 8.76% |
| 2018 Q3 | 178.32 Million JPY | -51.75% |
| 2018 Q1 | 117.9 Million JPY | -27.15% |
| 2018 Q2 | 369.61 Million JPY | 213.5% |
| 2017 FY | - JPY | 6.39% |
| 2017 Q4 | 161.83 Million JPY | -27.16% |
| 2017 Q3 | 222.19 Million JPY | -35.07% |
| 2017 Q2 | 342.19 Million JPY | 544.51% |
| 2017 Q1 | 53.09 Million JPY | -87.2% |
| 2016 FY | - JPY | 18.18% |
| 2016 Q1 | -36.08 Million JPY | -112.1% |
| 2016 Q2 | 280.59 Million JPY | 877.6% |
| 2016 Q4 | 414.82 Million JPY | 137.93% |
| 2016 Q3 | 174.34 Million JPY | -37.86% |
| 2015 Q1 | -3.35 Million JPY | -100.75% |
| 2015 FY | - JPY | -27.7% |
| 2015 Q4 | 298.3 Million JPY | 309.06% |
| 2015 Q3 | 72.92 Million JPY | -75.61% |
| 2015 Q2 | 298.99 Million JPY | 9009.33% |
| 2014 Q2 | 386.79 Million JPY | 3590.3% |
| 2014 Q3 | 191.59 Million JPY | -50.46% |
| 2014 Q4 | 448.73 Million JPY | 134.2% |
| 2014 FY | - JPY | 7.09% |
| 2014 Q1 | -11.08 Million JPY | -102.46% |
| 2013 Q2 | 338.66 Million JPY | 306.35% |
| 2013 Q3 | 43.79 Million JPY | -87.07% |
| 2013 Q4 | 450.64 Million JPY | 929.06% |
| 2013 FY | - JPY | 5.25% |
| 2013 Q1 | 83.34 Million JPY | -84.49% |
| 2012 Q1 | -75.22 Million JPY | -113.12% |
| 2012 Q4 | 537.31 Million JPY | 859.5% |
| 2012 FY | - JPY | -1.75% |
| 2012 Q3 | 56 Million JPY | -86.64% |
| 2012 Q2 | 419.02 Million JPY | 657.07% |
| 2011 Q1 | 128.94 Million JPY | -78.56% |
| 2011 Q2 | 412.38 Million JPY | 219.82% |
| 2011 Q3 | 117.97 Million JPY | -71.39% |
| 2011 Q4 | 573.13 Million JPY | 385.83% |
| 2011 FY | - JPY | -8.95% |
| 2010 Q2 | 571.56 Million JPY | 327.46% |
| 2010 FY | - JPY | -11.0% |
| 2010 Q1 | 133.71 Million JPY | -78.41% |
| 2010 Q3 | 46.76 Million JPY | -91.82% |
| 2010 Q4 | 601.52 Million JPY | 1186.23% |
| 2009 Q3 | 114.36 Million JPY | -82.0% |
| 2009 Q1 | 152.44 Million JPY | 0.0% |
| 2009 FY | - JPY | -6.22% |
| 2009 Q2 | 635.31 Million JPY | 316.74% |
| 2009 Q4 | 619.33 Million JPY | 441.56% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DVx Inc. | 807.98 Million JPY | -72.205% |
| Seikagaku Corporation | 2.09 Billion JPY | 33.617% |
| Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 75.611% |
| PHC Holdings Corporation | 39.08 Billion JPY | 96.44% |
| Techno Medica Co., Ltd. | 1.95 Billion JPY | 28.764% |
| Rion Co., Ltd. | 4.37 Billion JPY | 68.209% |
| Nihon Kohden Corporation | 23.44 Billion JPY | 94.065% |
| Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 96.16% |
| Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 88.77% |
| Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | 57.493% |
| 3-D Matrix, Ltd. | 2.09 Billion JPY | 33.49% |
| CYBERDYNE Inc. | -2 Million JPY | 69669.6% |